Dian Diagnostics Group Co.,Ltd. (SHE:300244)
18.66
+0.40 (2.19%)
Jul 20, 2026, 3:05 PM CST
Dian Diagnostics Group Market Cap
Dian Diagnostics Group has a market cap or net worth of 11.4 billion as of July 20, 2026. Its market cap has increased by 17.58% in one year.
Market Cap
11.40B
Enterprise Value
13.89B
Revenue
9.98B
Ranking
n/a
PE Ratio
88.11
Stock Price
18.66
ChartMarket Cap Chart
Since July 19, 2011, Dian Diagnostics Group's market cap has increased from 2.14B to 11.40B, an increase of 431.95%. That is a compound annual growth rate of 11.78%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 20, 2026 | 11.40B | 17.73% |
| Dec 31, 2025 | 9.69B | 39.54% |
| Dec 31, 2024 | 6.94B | -53.35% |
| Dec 29, 2023 | 14.88B | -5.54% |
| Dec 30, 2022 | 15.75B | -24.36% |
| Dec 31, 2021 | 20.83B | -2.07% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Joinn Laboratories(China)Co.,Ltd. | 32.24B |
| BGI Genomics | 13.80B |
| Guangzhou Kingmed Diagnostics Group | 12.22B |
| Amoy Diagnostics | 6.79B |
| Beijing Strong Biotechnologies,Inc. | 6.67B |
| Shanghai Runda Medical Technology | 5.85B |
| Maccura Biotechnology Co.Ltd | 5.48B |
| SMO ClinPlus CO.,LTD. | 4.30B |